Different sensitivity to amiloride of body and tail skins of Rana catesbeiana tadpoles during metamorphosis.
Regional differences in potential difference and short-circuit current between the body (dorsal) and the tail skin during metamorphosis of Rana catesbeiana tadpoles were investigated. In body skin, the potential difference and the short-circuit current across the skin develop in two successive steps. At stage XX, the potential difference and the short-circuit current across the body skins were amiloride-insensitive (1st step). At stage XXII, however, amiloride-sensitive potential difference and the short circuit current appeared (2nd step). By contrast, in tail skin the potential difference and the short-circuit current remained amiloride-insensitive (1st step) even at stage XXIII. Since the tail regresses after stage XXIII, the appearance of the second step could not be followed in vivo. To determine whether or not the second step can be induced in the tail, tail skin was cultured under conditions where the skin survives for a much longer period than it does in normally developing tadpoles. Such cultured tail skin generated the amiloride-sensitive potential difference and the short-circuit current and cultured body skin also generated them. Therefore, development of the 2nd step in the tail skin may be delayed in vivo. To characterize the differences between body and tail skin, skins were mutually grafted between body and tail at stage XIII-XV. The body skin grafted on the tail underwent both the 1st and 2nd steps by stage XXII, whereas the tail skin grafted on the body only showed the 1st step by the same stage. These results suggest that the regional specificity of the skin is already established before the prometamorphic stage.
Takada
M
M
Department of Physiology, Saitama Medical School, Japan.
D000584:Amiloride / Q000494:pharmacology*; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D046508:Culture Techniques; D004351:Drug Resistance; D017097:Electric Impedance; D007814:Larva / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism; D008564:Membrane Potentials / Q000187:drug effects; D008675:Metamorphosis, Biological; D010042:Ouabain / Q000494:pharmacology; D011892:Rana catesbeiana / Q000254:growth & development / Q000378:metabolism*; D012867:Skin / Q000187:drug effects* / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D013623:Tail
D010042:Ouabain; D000584:Amiloride; D012964:Sodium